B-LL with IGH::IL3 fusion is a rare, distinct entity described in the revised 4th Edition WHO Classification and retained in the 5th Edition WHO and the ICC [1,2,31]. The gene discussed is IL3; the disease is intrahepatic cholangiocarcinoma.